Amwill Healthcare IPO: A Comprehensive Analysis for Investors
Amwill Healthcare IPO is set to open for bidding on 5th February 2025. Recognized as an SME IPO, its tentative listing date is scheduled for 12th February 2025. The IPO consists of a book-built issue of 54,03,600 shares valued at Rs 59.98 crore. This includes a fresh issue of 44,03,600 shares worth Rs 48.88 crore and an offer for sale (OFS) of 10,00,000 shares worth Rs 11.10 crore.
This article offers a detailed analysis of Amwill Healthcare IPO, covering aspects such as financial health, technical indicators, issue size, grey market premium (GMP), and potential risks and benefits for investors.
Amwill Healthcare IPO Details
| Particulars | Details |
|---|---|
| IPO Open Date | 5th February 2025 |
| IPO Close Date | 7th February 2025 |
| IPO Allotment Date | 10th February 2025 |
| Refund Initiation | 11th February 2025 |
| Listing Date | 12th February 2025 |
| Issue Size | 54,03,600 shares (Rs 59.98 crore) |
| Face Value | Rs 10 per share |
| Lot Size | 1,200 shares |
| Price Band | Rs 105 to Rs 111 per share |
| Issue Type | Book Built Issue |
| Listing At | BSE & SME |
| Lead Manager | Unistone Capital Pvt. Ltd. |
| Registrar | Bigshare Services Pvt. Ltd. |
Amwill Healthcare IPO GMP & Market Sentiment
The grey market premium (GMP) provides insights into market sentiment regarding the IPO. GMP represents the difference between the IPO price band and the trading price in the unofficial grey market.
| GMP Date | GMP (Rs) | Estimated Listing Price (Rs) | Estimated Listing Gains (%) |
|---|---|---|---|
| 4th February 2025 | 13 | 124 | 11.71% |
| 3rd February 2025 | 0 | 111 | 0% |
| 2nd February 2025 | 0 | 111 | 0% |
| 1st February 2025 | 0 | 111 | 0% |
As of 4th February 2025, the GMP for Amwill Healthcare IPO stands at Rs 13 per share, implying a potential listing price of Rs 124 and estimated gains of 11.71% on the listing day.
Financial Performance
The financial health of Amwill Healthcare Limited plays a critical role in assessing the IPO’s potential.
Revenue & Profit Growth
During FY2023-24, the company’s revenue surged by 46.23%, reaching Rs 44.28 crore from Rs 30.28 crore in FY2022-23. Similarly, the profit after tax (PAT) grew by 303.21% from Rs 3.11 crore to Rs 12.54 crore.
Key Financial Ratios
| Indicator | Value |
|---|---|
| PE Ratio | 13.81 |
| PB Ratio | 10.09 |
| EPS (Earnings Per Share) | 8.04 |
| ROE (Return on Equity) | 73.06% |
| ROCE (Return on Capital Employed) | 94.16% |
| PAT Margin | 28.53% |
| Market Capitalization | Rs 222.04 crore |
Factors Influencing Amwill Healthcare IPO
1. Industry Growth and Demand
The healthcare and derma-cosmetic sector in India has seen consistent growth. Rising consumer awareness about skincare and dermatological solutions contributes to the increasing demand for such products.
2. Strong Financial Performance
With significant revenue and profit growth, Amwill Healthcare has positioned itself as a strong competitor in the industry.
3. Market Sentiment and GMP Trends
The rising GMP suggests positive investor sentiment, which could lead to substantial listing gains.
4. Risks and Challenges
- Low Market Capitalization: Compared to larger pharmaceutical and healthcare firms, Amwill Healthcare’s market capitalization is relatively small.
- High Lot Size: With a lot size of 1,200 shares, retail investors may find it challenging to allocate large investments.
- Competitive Industry: The healthcare and derma-cosmetic industry is competitive, with major players offering similar solutions.
About Amwill Healthcare Limited
Incorporated in August 2017, Amwill Healthcare specializes in derma-cosmetic products. The company collaborates with manufacturers, distributors, and third-party development agencies to enhance its manufacturing and distribution network. Its product portfolio includes generic dermatological solutions and targeted formulations for skin-related issues.
Comparison with Other IPOs
| Company | Opening Date | Closing Date |
|---|---|---|
| Chamunda Electricals Limited | 4th February 2025 | 6th February 2025 |
| Malpani Pipes and Fitting Ltd. | 29th January 2025 | 31st January 2025 |
| Dr. Agarwals Healthcare Ltd. | 29th January 2025 | 31st January 2025 |
| H.M. Electro Mech Ltd. | 24th January 2025 | 28th January 2025 |
| Denta Water and Infra Solutions Ltd. | 22nd January 2025 | 24th January 2025 |
Conclusion
Amwill Healthcare IPO presents a compelling investment opportunity for investors looking for exposure to the growing healthcare and derma-cosmetic sector. With strong financials, a favorable GMP, and positive market sentiment, it is expected to attract substantial investor interest. However, potential risks such as high lot size and industry competition should be considered before investing.
Investors are advised to conduct thorough research and consult financial advisors before making investment decisions in Amwill Healthcare IPO.
Disclaimer: The information provided above is for informational purposes only and should not be considered financial advice. Investors should download the Amwill Healthcare IPO RHP and DRHP for comprehensive details.
ALSO READ: Chamunda Electricals IPO: Should You Invest?
